Stem cell source, CD34+ dose and outcomes in haploidentical hematopoietic cell transplantation for myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Tomasz Czerw, Luuk Gras, Laurien GA Baaij, Massimiliano Gambella, Didier Blaise, Patrizia Chiusolo, Mi Kwon, Jakob Passweg, Alessandro Busca, Sandrine Loron, Patrice Ceballos, Mohamad Mohty, Fabio Ciceri, Radovan Vrhovac, Antonio Bianchessi, Matteo Parma, Hakan Ozdogu, Johannes Clausen, Linda Koster, Joanna Drozd-Sokolowska, Kavita Raj, Giorgia Battipaglia, Nicola Polverelli, Donal P. McLornan, Juan Carlos Hernández-Boluda Bone Marrow Transplantation
· Springer Nature
· 2026-11-17
· DOI: 10.1038/s41409-026-03018-5
Аннотация
Bone Marrow Transplantation, Published online: 17 November 2026; doi:10.1038/s41409-026-03018-5 Stem cell source, CD34+ dose and outcomes in haploidentical hematopoietic cell transplantation for myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Tomasz Czerw, Luuk Gras, Laurien GA Baaij, Massimiliano Gambella, Didier Blaise, Patrizia Chiusolo et al. Stem cell source, CD34+ dose and outcomes in haploidentical hematopoietic cell transplantation for myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT. // Bone Marrow Transplantation. – 2026. – DOI: 10.1038/s41409-026-03018-5. – URL: https://www.nature.com/articles/s41409-026-03018-5
Tomasz Czerw, Luuk Gras, Laurien GA Baaij, Massimiliano Gambella, Didier Blaise, Patrizia Chiusolo, Mi Kwon, Jakob Passweg, Alessandro Busca, Sandrine Loron, Patrice Ceballos, Mohamad Mohty, Fabio Ciceri, Radovan Vrhovac, Antonio Bianchessi, Matteo Parma, Hakan Ozdogu, Johannes Clausen, Linda Koster, Joanna Drozd-Sokolowska, Kavita Raj, Giorgia Battipaglia, Nicola Polverelli, Donal P. McLornan, & Juan Carlos Hernández-Boluda (2026). Stem cell source, CD34+ dose and outcomes in haploidentical hematopoietic cell transplantation for myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-026-03018-5
Tomasz Czerw, et al. “Stem cell source, CD34+ dose and outcomes in haploidentical hematopoietic cell transplantation for myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.” Bone Marrow Transplantation, 2026. doi:10.1038/s41409-026-03018-5.
@article{Czerw2026,
title = {Stem cell source, CD34+ dose and outcomes in haploidentical hematopoietic cell transplantation for myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT},
author = {Czerw, Tomasz and Gras, Luuk and Baaij, Laurien GA and Gambella, Massimiliano and Blaise, Didier and Chiusolo, Patrizia and Kwon, Mi and Passweg, Jakob and Busca, Alessandro and Loron, Sandrine and Ceballos, Patrice and Mohty, Mohamad and Ciceri, Fabio and Vrhovac, Radovan and Bianchessi, Antonio and Parma, Matteo and Ozdogu, Hakan and Clausen, Johannes and Koster, Linda and Drozd-Sokolowska, Joanna and Raj, Kavita and Battipaglia, Giorgia and Polverelli, Nicola and McLornan, Donal P. and Hernández-Boluda, Juan Carlos},
journal = {Bone Marrow Transplantation},
year = {2026},
doi = {10.1038/s41409-026-03018-5},
url = {https://www.nature.com/articles/s41409-026-03018-5}
}